Yu Yanlin
Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Cancers (Basel). 2023 Apr 16;15(8):2323. doi: 10.3390/cancers15082323.
Metastatic tumors cause the most deaths in cancer patients. Treating metastasis remains the primary goal of current cancer research. Although the immune system prevents and kills the tumor cells, the function of the immune system in metastatic cancer has been unappreciated for decades because tumors are able to develop complex signaling pathways to suppress immune responses, leading them to escape detection and elimination. Studies showed NK cell-based therapies have many advantages and promise for fighting metastatic cancers. We here review the function of the immune system in tumor progression, specifically focusing on the ability of NK cells in antimetastasis, how metastatic tumors escape the NK cell attack, as well as the recent development of effective antimetastatic immunotherapies.
转移性肿瘤导致癌症患者死亡的人数最多。治疗转移仍然是当前癌症研究的主要目标。尽管免疫系统能够预防和杀死肿瘤细胞,但几十年来,免疫系统在转移性癌症中的作用一直未得到重视,因为肿瘤能够形成复杂的信号通路来抑制免疫反应,从而使其逃避检测和清除。研究表明,基于自然杀伤(NK)细胞的疗法在对抗转移性癌症方面具有诸多优势和前景。我们在此综述免疫系统在肿瘤进展中的作用,特别关注NK细胞的抗转移能力、转移性肿瘤如何逃避NK细胞的攻击,以及有效的抗转移免疫疗法的最新进展。